Skip to content

Amgen AMGN Change in Income Taxes

Change in Income Taxes at other companies

Pfizer logo
PfizerPFE
-$701.25M-109%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$37.4M+188%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$1.89M
Roivant Sciences logo
Roivant SciencesROIV
$21.26M+946%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$195.44B+34.6%
Enterprise value$252.2B+25.7%
P/E25.1×+3.1×
P/S5.3×+1.1×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's change in income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's change in income taxes?
Amgen (AMGN) reported change in income taxes of $71M in Q1 2026.
How has Amgen's change in income taxes changed year-over-year?
Amgen's change in income taxes decreased by 31.7% year-over-year, from $104M to $71M.
What does change in income taxes mean?
Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.